0001144204-12-040012.txt : 20120718
0001144204-12-040012.hdr.sgml : 20120718
20120718164929
ACCESSION NUMBER: 0001144204-12-040012
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20120718
DATE AS OF CHANGE: 20120718
EFFECTIVENESS DATE: 20120718
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CURE PHARMACEUTICAL Corp
CENTRAL INDEX KEY: 0001554289
IRS NUMBER: 452717791
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-181465
FILM NUMBER: 12968309
BUSINESS ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
BUSINESS PHONE: 805 824 0410
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
D
1
primary_doc.xml
X0706
D
LIVE
0001554289
CURE PHARMACEUTICAL Corp
1620 BEACON PLACE
OXNARD
CA
CALIFORNIA
93033
805 824 0410
CALIFORNIA
None
None
Corporation
true
2011
Robert
Davidson
1620 BEACON PLACE
OXNARD
CA
CALIFORNIA
93033
Executive Officer
Director
Edward
Maliski
1620 BEACON PLACE
OXNARD
CA
CALIFORNIA
93033
Executive Officer
Director
Mark
Udell
1620 BEACON PLACE
OXNARD
CA
CALIFORNIA
93033
Executive Officer
Wayne
Nasby
1620 BEACON PLACE
OXNARD
CA
CALIFORNIA
93033
Executive Officer
Director
Jonathan
Turman
1620 BEACON PLACE
OXNARD
CA
CALIFORNIA
93033
Executive Officer
Director
Vic
Branstetter
1620 BEACON PLACE
OXNARD
CA
CALIFORNIA
93033
Director
Manufacturing
$1,000,001 - $5,000,000
- 06
false
2012-07-10
false
true
true
false
15000
958568
958568
0
false
12
0
0
958568
Consideration paid was in the form of Secured Promissory Notes.
false
CURE PHARMACEUTICAL Corp
/s/ Mark Udell
Mark Udell
Chief Financial Officer
2012-07-18